The aim of regenerative medicine is to regenerate the function of damaged tissues and organs by using cells in creative ways. This particular field of medicine, which capitalizes on the regenerative capability of cells, is called “third medicine” to distinguish it from conventional medical techniques, which include surgical treatment and transplantation.
In recent years, regenerative medical technology for cornea, teeth, skin, cartilage, cardiac muscle, and nerves have made advances in studies domestically and internationally. At the present day, we at ArBlast focus on the regeneration of cornea and R&D for products related to regeneration using mesenchymal stem cells.

While corneal diseases result in visual impairment in 20,000 patients every year in Japan, there are only 1,500 corneal transplants. Application of corneal regenerative medical not only gives light to patients who are waiting for cornea transplants, but it also enables to treat severe ocular surface diseases, which do not have any effective methods of treatment at present. Mesenchymal stem cell has a potential to differentiate into a variety of tissues like bone, cartilage, cardiac muscle,and nerve, and it plays a key role in the development of regenerative medicine. With these bright prospects, regenerative medicine is expected to develop into a major business field in the years ahead.

ArBlast has two main technologies: 1) a technology to pick out cells, which play a vital role in regenerative medicine, culture them and combine them with an appropriate platform, and 2) a technology for producing collagen sheet from human amniotic membrane for use as a culture scaffold for various cells. Our core value is to develop products that are verified by pre-clinical evaluations like tumorigenecity tests or virus clearance tests for safety and quality, which are crucial for products using cells, and to construct stable manufacturing and supplying system in the cycle of regenerative medicine. By networking with researchers engaged in cutting-edge research projects and by making the most of Kobe Medical Industry City’s infrastructure, ArBlast is striving to develop new areas in which to apply its technologies.

As a manufacturer of regenerative medicine materials, ArBlast seeks to serve as a bridge between researchers/medical institutions and patients. By conducting all business activities on its own, from research, development and manufacture to distribution, ArBlast hopes to establish an unmatchable presence as a leading company in the regenerative medicine industry.
We develop cell-engineered medical materials for corneal diseases and other various diseases.